MetaCap

Universe Pharmaceuticals (UPC) vs Exicure (XCUR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Exicure is the larger company by market cap ($5.9 million vs $5.4 million), about 1.1 times the size, while Universe Pharmaceuticals is growing revenue faster (-22.4% vs -100.0%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

UPC-74.91%XCUR-11.75%
+23%-28%-80%
Oct 7, 20261 yearNov 20, 2026
UPC-73.98%XCUR-14.28%
+11%-34%-78%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

UPC versus XCUR key metrics
MetricUPCXCUR
Share price$1.08$0.9001
Market cap$5.43M$5.89M
1-day change-20.59%-12.82%
YTD return-71.65%—
1-year return-68.24%—
5-year return-99.99%—
EPS (TTM)$-1.38$-1.31
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$17.86B$0
Revenue growth (YoY)-22.44%-100.00%
Net income (latest FY)$-3.67B$-4.95M
Gross margin35.28%—
Operating margin-16.33%—
Net margin-20.56%—
52-week high$17.96$9.48
52-week low$1.05$0.777
Distance from 52-week high-93.99%-90.51%
Average volume176.76K53.56K
Shares outstanding5.01M6.55M
Employees2161
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Universe Pharmaceuticals grew revenue faster in its latest fiscal year (-22.44% vs -100.00%).

About Universe Pharmaceuticals

UPC stock →

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications.

Health Care · Biotechnology: Pharmaceutical Preparations · 216 employees

About Exicure

XCUR stock →

Exicure, Inc. does not have significant operations.

Health Care · Biotechnology: Pharmaceutical Preparations · 1 employees

UPC vs XCUR FAQ

Which is bigger, Universe Pharmaceuticals or Exicure?

Exicure (XCUR) is larger, with a market capitalization of $5.89M compared with $5.43M for Universe Pharmaceuticals (UPC).

Are Universe Pharmaceuticals and Exicure in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons